-
Study aim
-
Determination of the effectiveness of low-dose ketamine with dexmedetomidine, and its comparison with morphine in controlling pain in patients with limb trauma referred to the emergency department
-
Design
-
Clinical trial, with a parallel-group, double-blind, randomized, phase 3 on 258 patients. Using Block Stratified Randomization software, Windows version 6.0 is randomly divided into two categories.
-
Settings and conduct
-
258 adult patients who were referred to the emergency department with pain due to limb trauma are randomly divided into two groups. After obtaining informed consent to participate in the study, they receive the drugs, then by comparing the scores they have suffered before and after taking the drug (at intervals of 5, 10, and 15 minutes after injecting the drug) and We will also discuss the possible benefits of this alternative method for its side effects.
-
Participants/Inclusion and exclusion criteria
-
Adult patients who have been referred to the Sina Hospital emergency department with limb trauma.
Patients with the following characteristics will not be included in the study
1. Pain score ≤ 5, 2. Pregnancy and post-partum women, 3. Altered mental status, 4. Allergy to ketamine or morphine or dexmedetomidine, 5. Bodyweight ≤ 46 kg or ≥ 115, 6. Unstable vital signs: BP≤ 90 mmHg or ۸ 180 mmHg, PR≥150 or ≤50 bits/min, RR≤10 or ≥30, 7. History of the recent head or eye trauma, 8. History of seizure, 9. History of elevated ICP, 10. Chronic pain, ۱۱. Renal or hepatic failure, 12. Substance or alcohol abuse, 13. Documented psychiatric disorders, 14. Opium addiction, 15. Recent use of narcotic analgesics
-
Intervention groups
-
Two groups of intravenous sub dissociative ketamine (0.3 mg/kg) with (1 mcg/kg) intravenous dexmedetomidine or intravenous morphine (0.1 mg/kg).
-
Main outcome variables
-
Pain intensity; blood pressure; heartbeat; Number of breaths; drug side effects; rescue analgesia